Article
Ancestry and other genetic associations with plasma PCSK9 response to simvastatin.
Pharmacogenetics and genomics - 1 Oct 2014
Theusch Elizabeth, Medina Marisa W, Rotter Jerome I, Krauss Ronald M
Abstract excerpt
OBJECTIVE: Statins stimulate transcription of proprotein convertase subtilisin/kexin type 9 (PCSK9), a negative regulator of the low-density lipoprotein receptor, thus blunting the cholesterol-lowering effects of statin treatment. Although there is interindividual variation in PCSK9 statin response, little is known about ancestral and other genetic factors that could contribute to this variation. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
